Table 1.
Drug therapies administered in patients with hypertension and/or diabetes
| Total | DIA without HYP | DIA with HYP | HYP without DIA | |
|---|---|---|---|---|
| Antihypertensive drugs (%) | 47.21 | 100.00 | 58.19 | |
| Diuretics (%) | 41.67 | 50.00 | 43.26 | |
| ACEi (%) | 39.58 | 43.75 | 33.65 | |
| ARB (%) | 34.03 | 40.00 | 35.58 | |
| β-blockers (%) | 29.86 | 31.25 | 32.69 | |
| α-blockers (%) | 5.56 | 7.50 | 2.88 | |
| Calcium antagonists (%) | 18.06 | 23.75 | 18.27 | |
| Other antihypertensive drugs (%) | 1.39 | 0.00 | 1.92 | |
| Antidiabetic drugs (%) | 21.987 | 84.38 | 87.50 | |
| Insulin (%) | 20.90 | 29.63 | 20.00 | |
| Metformin (%) | 83.58 | 85.19 | 80.00 | |
| Sulfonylureas (%) | 32.84 | 14.81 | 37.14 | |
| Meglitinides (%) | 2.99 | 7.41 | 4.29 | |
| α-glucosidase inhibitors (%) | 1.49 | 1.43 | ||
| Glitazones (%) | 7.14 |
Data are expressed as percentages. ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; DIA, patients with diabetes; HYP, patients with hypertension.